GP Circular 014/26 MMP Preferred Proton Pump Inhibitor - Pantoprazole

GP Circular 14/26 provides information to clinicians on the MMP Preferred Drugs Initiative namely, the preferred PPI, Pantoprazole. The preferred drug initiative identifies a single ‘preferred drug’ within a therapeutic class, and offers prescribers useful guidance on selecting, prescribing and monitoring this drug for a particular condition.